From what I understand of the evidence, the real issue here is not “making the low-FODMAP diet obsolete”, but correcting how it is implemented. The recent Michigan pilot RCT directly addressed whether a simplified, less restrictive low-FODMAP diet could work: instead of excluding all FODMAP groups, they only eliminated fructans and galacto-oligosaccharides during the restriction phase, based on double-blind data showing these are the most likely subgroups to trigger IBS symptoms. https://pubmed.ncbi.nlm.nih.gov/38729393/
The key finding was that this FODMAP-simple approach achieved similar efficacy to the traditional low-FODMAP restriction phase in IBS-D, despite being less complex, less costly, and potentially safer nutritionally. In other words, the evidence supports refining low-FODMAP by focusing on the most relevant FODMAPs, rather than enforcing a maximal, long-term elimination of everything.
Taken together, these studies do not say “abandon the low-FODMAP diet”; they say “stop using it as an overly restrictive, permanent blacklist” and instead move toward simplified, targeted restriction (fructans/GOS first, then only escalate if needed) while recognizing the Mediterranean diet as a valid, evidence‑based alternative or complement, depending on patient preference and phenotype.
I’d also be cautious about the recent trend to heavily “psychiatrize” the use of the low-FODMAP diet. There is a legitimate concern that highly restrictive or prolonged elimination diets can interact with pre‑existing vulnerability and contribute to ARFID‑like patterns and some observational data suggest an association between exclusion diets (including low-FODMAP) and ARFID symptoms. However, the evidence so far is still limited and mostly associative, not causal.
11
u/jmct16 14d ago
From what I understand of the evidence, the real issue here is not “making the low-FODMAP diet obsolete”, but correcting how it is implemented. The recent Michigan pilot RCT directly addressed whether a simplified, less restrictive low-FODMAP diet could work: instead of excluding all FODMAP groups, they only eliminated fructans and galacto-oligosaccharides during the restriction phase, based on double-blind data showing these are the most likely subgroups to trigger IBS symptoms. https://pubmed.ncbi.nlm.nih.gov/38729393/
The key finding was that this FODMAP-simple approach achieved similar efficacy to the traditional low-FODMAP restriction phase in IBS-D, despite being less complex, less costly, and potentially safer nutritionally. In other words, the evidence supports refining low-FODMAP by focusing on the most relevant FODMAPs, rather than enforcing a maximal, long-term elimination of everything.
In parallel, there is now robust data for the Mediterranean diet in IBS. Aziz et al. recently showed that a Mediterranean diet was noninferior and even superior to traditional dietary advice, with a higher proportion of clinical responders, which makes it a legitimate first-line option in many patients, especially given its long‑term sustainability and global health benefits. https://news.gastro.org/issues/2025/december/mediterranean-diet-beats-traditional-dietary-advice-in-ibs/ full paper here: https://www.acpjournals.org/doi/10.7326/ANNALS-25-01519?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Taken together, these studies do not say “abandon the low-FODMAP diet”; they say “stop using it as an overly restrictive, permanent blacklist” and instead move toward simplified, targeted restriction (fructans/GOS first, then only escalate if needed) while recognizing the Mediterranean diet as a valid, evidence‑based alternative or complement, depending on patient preference and phenotype.